Assertio Holdings (ASRT) Hisse Özeti
Bir ilaç şirketi olan Assertio Holdings, Inc. Amerika Birleşik Devletleri'ndeki hastalara çeşitli ürünler sunmaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 3/6 |
| Gelecekteki Büyüme | 3/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 6/6 |
| Temettüler | 0/6 |
Ödüller
Risk Analizi
Risk kontrollerimizden ASRT için herhangi bir risk tespit edilmedi.
ASRT Community Fair Values
Create NarrativeSee what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Assertio Holdings, Inc. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$23.32 |
| 52 Haftanın En Yüksek Seviyesi | US$23.36 |
| 52 Haftanın En Düşük Seviyesi | US$8.61 |
| Beta | 0.45 |
| 1 Aylık Değişim | 29.48% |
| 3 Aylık Değişim | 93.53% |
| 1 Yıllık Değişim | 118.69% |
| 3 Yıllık Değişim | -77.92% |
| 5 Yıllık Değişim | 2.96% |
| Halka arzdan bu yana değişim | -90.28% |
Son Haberler & Güncellemeler
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.Recent updates
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.
ASRT: Reverse Split And 2026 Guidance Will Shape Future Upside Potential
Analysts have kept Assertio Holdings' fair value estimate steady at $28.00, while modestly refining their assumptions around revenue growth, profit margins, and future P/E. This has led to a recalibrated price target that they see as better aligned with updated fundamentals.ASRT: Reverse Split And 2026 Guidance Will Reshape Risk Reward Profile
Analysts have raised their price target on Assertio Holdings from $1.75 to $28.00, citing updated assumptions for revenue growth, profit margins, discount rate, and a lower future P/E multiple in their models. Analyst Commentary Even with a sharply higher price target in some models, not all research views point in the same direction for Assertio Holdings.ASRT: Reverse Split And Earnings Power Will Support Rerating Potential
Analysts have raised their price target on Assertio Holdings, maintaining the figure at $37.44, while citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E as the reasons for the revised assessment. Analyst Commentary Bullish Takeaways Bullish analysts view the reaffirmed $37.44 price target as consistent with their updated fair value work, suggesting the current share price still leaves room for upside if execution tracks their assumptions.
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have revised their price target for Assertio Holdings to $45.00. The update reflects slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E expectations.Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders would be excited to see that the share price has had a great...ASRT: Reverse Split And Earnings Visibility Will Reframe Risk Reward Profile
Analysts have modestly adjusted their price target for Assertio Holdings, citing updated views on discount rates, long term revenue trends and sustainable profit margins, along with a slightly higher assumed future P/E multiple. Analyst Commentary Recent Street research on a comparable operator in the transport and infrastructure space, Asur, offers a useful reference point for how analysts are currently weighing valuation against execution risk when traffic and revenue visibility are in focus.ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have trimmed their price target on Assertio Holdings to $45.00 from $44.99, reflecting updated assumptions that indicate a smaller revenue decline, higher profit margins near 15%, and a lower future P/E closer to 16x. Analyst Commentary Bullish analysts in the wider market are pointing to companies that maintain or improve profitability targets and trade on mid-teens P/E multiples as potential opportunities for re-rating when execution holds up.ASRT: Reverse Split And New Leadership Will Reframe Risk Reward Profile
Analysts lifted their fair value estimate for Assertio Holdings from $2.69 to $37.44, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E as the key drivers of the new price target range. Analyst Commentary Recent Street research on airport operators with similar business profiles offers some context for how analysts might be thinking about Assertio Holdings, particularly around traffic trends, valuation ranges, and the balance between upside potential and execution risk.ASRT Will Rely On Cost Discipline To Support Future Upside Potential
Analysts have raised their price target on Assertio Holdings significantly, from approximately $3.00 to about $45.00. This reflects a higher assumed fair value multiple despite more conservative expectations for revenue growth and profit margins.Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy...Is Assertio Holdings (NASDAQ:ASRT) Using Debt In A Risky Way?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Assertio Holdings, Inc. ( NASDAQ:ASRT ) missed earnings with its latest first-quarter results, disappointing...Is Assertio Holdings (NASDAQ:ASRT) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Rolvedon And Sympazan Will Create New Market Opportunities
Strategic market penetration and increased commercial efforts for Rolvedon and Sympazan aim to boost revenue growth.Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues Are Not Doing Enough For Some Investors
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a strong buy...Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders that were waiting for something to happen have been dealt a blow...Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have retraced a considerable 30% in the last month, reversing a fair...There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 36...Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 29...Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders are no doubt pleased to see that the share price has bounced 26...Hissedar Getirileri
| ASRT | US Pharmaceuticals | US Pazar | |
|---|---|---|---|
| 7D | 4.3% | 1.4% | -0.3% |
| 1Y | 118.7% | 34.5% | 24.1% |
Getiri vs. Endüstri: ASRT geçen yıl % 34.5 oranında getiri sağlayan US Pharmaceuticals sektörünü aştı.
Getiri vs Piyasa: ASRT geçen yıl % 24.1 oranında getiri sağlayan US Piyasasını aştı.
Fiyat Oynaklığı
| ASRT volatility | |
|---|---|
| ASRT Average Weekly Movement | 9.2% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
İstikrarlı Hisse Senedi Fiyatı: ASRT son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: ASRT 'nin haftalık oynaklığı ( 9% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 2020 | 53 | Mark L. Reisenauer | www.assertiotx.com |
Bir ilaç şirketi olan Assertio Holdings, Inc. Amerika Birleşik Devletleri'ndeki hastalara çeşitli ürünler sunmaktadır. Farmasötik ürünleri arasında, kronik hastalığın akut alevlenmeleri de dahil olmak üzere orta ila şiddetli romatoid artrit, ankilozan spondilit ve osteoartrit ve akut ağrılı omuz ve gut artriti tedavisi için oral ve fitil solüsyonu olan INDOCIN bulunmaktadır. Ayrıca iki yaş ve üzeri hastalarda lennox-gastaut sendromu ile ilişkili nöbetlerin ek tedavisi için bir benzodiazepin olan Sympazan; migren ağrısı, bulantı, fotofobi ve fonofobi tedavisi için bir non steroidal anti inflamatuar ilaç (NSAID) olan CAMBIA'yı da sunmaktadır; Opioid düzeyinde analjezi gerektiren orta ila orta derecede şiddetli ağrının kısa süreli yönetimi için bir NSAID olan SPRIX; ve febril nötropeninin neden olduğu enfeksiyon insidansını azaltmak için endike olan uzun etkili bir granülosit koloni uyarıcı faktör olan ROLVEDON.
Assertio Holdings, Inc. Temel Bilgiler Özeti
| ASRT temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$150.70m |
| Kazançlar(TTM) | -US$35.69m |
| Gelir(TTM) | US$102.16m |
ASRT aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| ASRT gelir tablosu (TTM) | |
|---|---|
| Gelir | US$102.16m |
| Gelir Maliyeti | US$30.31m |
| Brüt Kâr | US$71.85m |
| Diğer Giderler | US$107.54m |
| Kazançlar | -US$35.69m |
Son Raporlanan Kazançlar
Mar 31, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | -5.52 |
| Brüt Marj | 70.33% |
| Net Kâr Marjı | -34.94% |
| Borç/Özkaynak Oranı | 51.9% |
ASRT uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/18 07:30 |
| Gün Sonu Hisse Fiyatı | 2026/05/15 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Assertio Holdings, Inc. 18 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Scott Henry | Alliance Global Partners |
| null null | Argus Research Company |
| Kenneth Trbovich | Brean Capital Historical (Janney Montgomery) |